History and Mission
Americord was founded in 2008 with a commitment to helping our customers and their children live healthier, longer lives. We set out to pioneer the development of new cord blood and tissue banking technologies and innovations to better achieve these goals and serve our customers.
This dedication to innovation under the leadership of Executive Medical Director Dr. Robert Dracker led to Cord Blood 2.0TM, our proprietary process for cord blood collection that allows us to collect up to twice as many stem cells as a traditional cord blood collection method.
We were also one of the first companies in the world to offer cord tissue and placental tissue banking. In 2011 we debuted our cord tissue collection offerings and the following year we began banking placental tissue and continue to be a pioneer in this space.
Americord’s commitment to innovation is never complete. We continuously research ways to improve our collection, processing, and banking procedures. We often partner with institutions nation-wide and around the globe to advance not only the technology that makes our service possible but also the R&D that will make the regenerative medicine more viable in the future.
Most importantly, we are in constant contact with our growing family—our clients—regarding innovations we make.
What Parents Who Banked Have to Say
“I had a million questions about cord blood banking. The staff at Americord answered them all and even explained complicated things about stem cells in plain language. They also walked me through the different options and payment plans and helped me find the one that was right for me.”
“When I began researching cord blood banks, I wanted to find the one with the highest standards – even if that meant I had to pay more. What a great surprise to find out that I could get the best service and the highest quality at half the price with Americord!”
“We decided to save our baby’s stem cells because it seems like every day there are new treatments for diseases that used to be incurable. We chose Americord because it is constantly investing in innovations in stem cell preservation and it offers cord blood products that are not available from other companies.”
“Given the advances in genetic research and the potential for life saving or possibly advancing technology, I felt it would be an investment in our child’s health to save his cord blood. After shopping around, Americord offers the most value and was extremely customer friendly. This was important to me, being a first time mother. I am recommending Americord to all of my friends.”